NF1 and breast carcinoma: In other studies, inhibitors of PI3K, the downstream effector of the Ras pathway, were shown to inhibit the growth of NF1-mutated MPNST cells and neurofibromin-deficient human breast cancer xenografts in mice [63, 64].